China Economic Weekly-Economic Net news a few days ago, the science and technology innovation board enterprise Zedda Yisheng (688555) released 2021 semi-annual report. The company realized operating income of 142 million yuan, up 30.61% year-on-year, and net profit of 24.7631 million yuan, up 1.83% year-on-year. The company said that during the reporting period, the company strengthened its own technical capabilities, and actively promote the research of core technologies and product transformation, so that the expansion of new business brings increased sales revenue, and further actively explore the market and increase market share.
With a deep understanding of the pharmaceutical industry, ZetaEssentia has emerged in the main track of pharmaceutical informatization, the company has created a core technology group of cross-fertilization and innovation of information and medicine, and created two major informatization platforms of intelligent pharmaceutical production and intelligent pharmaceutical circulation, and extended its business to the upstream of the industrial chain in the field of agriculture, and to use informatization technology to promote the high-quality development of pharmaceutical and health industry.
R&D and Ecology Performance
The company said in its half-yearly report that it will continue to invest in R&D and make new breakthroughs in technology, which will further strengthen its core technological advantages and enhance its competitive barriers in the market.
During the reporting period, the company added 7,080,800 yuan of research and development expenses, an increase of 69.34% year-on-year, and increased investment in equipment and software. As of the end of the reporting period, the company has been authorized 21 patents (including 18 invention patents), 194 software copyrights. Among them, 13 new software copyrights in the first half of 2021, a total of 39 software products.
The company has always adhered to the concept of data-driven, fast service-oriented, cloud-native ideas and machine learning technology to build a knowledge graph to describe the production state and appearance of the enterprise, to locate the scope of the enterprise management indicators, and to achieve the transformation and upgrading of the pharmaceutical manufacturing enterprises from digitalization to networking and intelligentization.
From the perspective of product line, Zeta ECS consolidates the Zeta Micro Intelligent Manufacturing Platform product line, based on containerization + micro-service technology architecture, to achieve agile development and continuous operation and maintenance, to further deepen the industrial software system of the production execution system MES, manufacturing operation system MOM, quality management system QMS, resource management system EAM, from the collection of industrial interconnectivity access, process control, manufacturing decision-making and reverse regulation, to the implementation, operation decision-making and reverse regulation, and to the implementation of industrial interconnectivity. execution, operation decision-making and reverse regulation, realizing the whole chain data closed loop.
By service segment, in the pharmaceutical distribution enterprise service segment, ZetaEssentia develops and promotes HIS systems for various clinics, health centers, small hospitals and other medical institutions, opening up the medical insurance data interface, realizing one-stop clinic informatization solutions, and promoting the optimization of the market resource allocation and circulation efficiency, with the aim of creating the service closed loop of "Internet+Pharmaceuticals+Medicine". The aim is to create a closed loop of "Internet+Pharmaceutical and Medical" services. In this ecosystem, pharmaceutical companies, pharmaceutical companies, pharmacies, hospitals, patients can break the isolation state, integration and interconnection as one.
Continuous investment in R&D and technological innovation has brought ZetaEssentia a strong guarantee for business development, and the company's comprehensive strength, industry influence, and brand building have been continuously improved. During the reporting period, the company was successfully approved for ITSS Level 2 certification, and was recognized as a AAA grade credit enterprise. The first "Digital Countryside Standard System Construction Guidelines" drafted by the company as the core group standard was formally released. The company's wholly-owned subsidiary, Suzhou ZEDA, was also approved as the third batch of professional service providers for the industrial Internet platform in the Yangtze River Delta's G60 Science and Innovation Corridor, and was selected to become a member of China's Intelligent Manufacturing System Solution Providers Alliance, and participated in the National Ministry of Industry and Information Technology's "Thirteenth Five-Year" Intelligent Manufacturing New Mode Project as a joint unit, which was also accepted.
Capture the opportunity to expand the space to usher in the development of the golden period
At present, in the policy guidance, technology-driven as well as endogenous demand for the role of the ****, medical information technology industry is ushering in the golden period of development.
ZetaEssentia is an early layout of the pharmaceutical industry chain information technology enterprises. Starting from the pharmaceutical distribution information technology business, after several years of cultivation and independent innovation, gradually expanding the business to the pharmaceutical production information technology, medical information technology and industry chain upstream of the agricultural field of information technology, which in the field of medical information technology to the pharmaceutical distribution of information technology products as the basis for the development of the remote diagnosis and treatment, prescription, online consultation, medical AI auxiliary diagnostic and treatment service system and customer service based on the management of chronic diseases, electronic medical records, health records and other services. In the field of pharmaceutical informatization, the company has developed service systems such as remote diagnosis and treatment, prescription prescribing, online consultation, medical AI-assisted diagnosis and treatment, and management platforms based on customer service such as chronic disease management, electronic medical records and health records. During the reporting period, the technological research and development capability of the remote follow-up diagnosis platform and intelligent medical big data analysis application platform under research and development is even at the domestic advanced level. At present, the company's business has covered more than 20 provinces, municipalities and autonomous regions, such as Zhejiang Province, Fujian Province, Sichuan Province. ZetaEssentia's self-developed industrial software platform has achieved localized substitution, breaking through the previous situation of international brand dominance.
According to the Ministry of Industry and Information Technology Operation Monitoring and Coordination Bureau data statistics, from 2010 to 2020, China's software and information technology services industry revenue from 1.36 trillion yuan in 2010 to 8.16 trillion yuan in 2020, the compound annual growth rate of 19.6%, showing a trend of steady growth. 2021 the first half of China's software and information technology services industry business revenue 4.42 trillion yuan, an increase of 23.2%.
Industry analysts said that, compared with the high concentration of the pharmaceutical industry abroad, the domestic pharmaceutical industry concentration is also rapidly increasing, large pharmaceutical companies will further open the information technology market. In addition, because the pharmaceutical industry and the people's health is closely related to the national level, the health of the field of medium and long-term strategic planning, will guide the field of health into the digital management of the new stage of development.
In the field of agriculture, ZetaEssentia focused on the study of "planting a thing" during the reporting period, training long-lasting planting algorithms, and improving the quality and efficiency of agricultural products through scientific breeding and intelligent cultivation; at the same time, perfecting the agricultural informatization platform, and iteratively upgrading the Internet of Things and traceability platforms, with the main direction of the agricultural industrial parks and regional agricultural products. At the same time, we improve the agricultural informatization platform, and in the main direction of agricultural industrial parks and regional agricultural products, iteratively upgrade the Internet of Things and traceability platforms to create a one-standard, two-code brand control system and enhance the brand credibility of agricultural products; and in the rural area, we build a rural data base to collect, integrate, analyze, and ****enjoy the collection and use of agricultural data resources through data aggregation, data cleansing and governance, and data operation and monitoring.
In the process of development, ZetaEssentia, on the one hand, broadens and expands its business coverage, and on the other hand, deepens and serves the pharmaceutical distribution ecosystem integrating plantation enterprises, pharmaceutical enterprises, pharmaceutical companies, pharmacies, hospitals, and patients, and ultimately realizes the optimization of the pharmaceutical and healthcare industrial chain. The company focuses y on the field of medicine and health, builds the core industrial map, and expands the informationization business of the whole pharmaceutical field, such as biopharmaceuticals and chemical pharmaceuticals, in the process of the deep fusion of industrialization and informationization, with the improvement of the industry's process level as the entry point.